CUSIP: 87164U102
Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
35,648,816
-
Share change
-
+3,244,264
-
Total reported value
-
$64,175,811
-
Price per share
-
$1.80
-
Number of holders
-
68
-
Value change
-
+$5,357,278
-
Number of buys
-
38
-
Number of sells
-
24
Quarterly Holders Quick Answers
What is CUSIP 87164U102?
CUSIP 87164U102 identifies SYN - SYNTHETIC BIOLOGICS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2016
-
Previous quarter:
Q1 2016
Recent filing periods for CUSIP 87164U102:
Institutional Holders of SYNTHETIC BIOLOGICS INC - COM (SYN) as of Q2 2016
As of 30 Jun 2016,
SYNTHETIC BIOLOGICS INC - COM (SYN) was held by
68 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,648,816 shares.
The largest 10 holders included
Third Security, LLC, Knoll Capital Management, LP, MSD Partners, L.P., VANGUARD GROUP INC, BLAIR WILLIAM & CO/IL, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., STATE STREET CORP, NORTHERN TRUST CORP, and BRIDGEWAY CAPITAL MANAGEMENT INC.
This page lists
68
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.